Germany· DE-A57-139f98e01a7ef259
Carboplatin Kabi
A carboplatin product containing carboplatin, registered in Germany by Fresenius Kabi Deutschland Gmbh. The same ATC class is registered in 17 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Carboplatin is registered in 17 of 19 countries.
Countries holding a registration under ATC L01XA02 (carboplatin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 9 of them publish a price we can compare per daily dose
Carboplatin · ATC L01XA02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of carboplatin costs, country by country.
Normalised to the WHO defined daily dose (25 mg), the median price runs from $0.34 in Czechia to $7.73 in Switzerland — a ×23 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Carboplatin · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- CH Switzerland$7.73
- CZ Czechia$0.34
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Carboplatin
- Manufacturer
- Fresenius Kabi Deutschland Gmbh
- Country
- Germany (DE)
- ATC code
- L01XA02
- ATC class
- Carboplatin
- Defined daily dose
- 25 mg, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
564 interactions on record for carboplatin.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Carboplatin · interactions on record
564 records
- 37 severe
- 205 moderate
- 15 minor
- 307 info
Most severe, free to view
- CidofovirJ05AB12severe
- ThiotepaL01AC01severe
- CladribineL01BB04severe
- TopotecanL01CE01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Carboplatin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCarboplatin 1000mg/500ml in Glucose 5% infusion bagsSpecial Order
- United StatesCarboplatinHospira, Inc.
- BelgiumCarboplatin Accord Healthcare 10 mg/mlAccord Healthcare
- SwitzerlandCarboplatin Accord
- FinlandCarboloxJacobsen Pharma AS
- CzechiaCARBOPLATIN ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- FranceCARBOPLATINE ACCORD 10 mg/ml, solution pour perfusionACCORD HEALTHCARE FRANCE
- SpainCARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Carboplatin Accord, Carboplatin Ebewe
- Belgium · Carboplatin Accord Healthcare, Carboplatin Eugia
- Bulgaria · Карбоплатин Ебеве
- Cyprus · Carboplatin Accord, Carboplatin Accord Healthcare
- Czechia · Carboplatin Accord, Carboplatin Kabi
- Denmark · Carbomedac, Carboplatin "ebewe"
- Estonia · Carboplatin Accord, Carboplatin Kabi
- Spain · Carboplatino Accord, Carboplatino Aurovitas
- Finland · Carboplatin Accord, Carboplatin Ebewe
- France · Carboplatine Accord, Carboplatine Arrow Lab
- United Kingdom (Northern Ireland) · Carboplatin Accord Healthcare, Carboplatin Amarox
- Greece · Carboplan, Carboplatin Hospira
- Croatia · Karboplatin Accord, Karboplatin Pontus
- Hungary · Carboplatin Accord, Carboplatin Kabi
- Ireland · Carboplatin, Carboplatin Accord Healthcare Ireland
- Iceland · Carboplatin Actavis, Carboplatin Fresenius Kabi
- Italy · Carboplatino Ahcl, Carboplatino Aurobindo Italia
- Lithuania · Carboplatin Accord, Carboplatin Kabi
- Luxembourg · Carboplatine Fresenius Kabi, Carboplatine Onco-Tain Hospira
- Latvia · Carboplatin Accord, Carboplatin Ebewe
- Malta · Carboplan, Carboplatin Accord Healthcare
- Netherlands · Carboplatin Accord, Carboplatine Fresenius Kabi
- Norway · Carbomedac, Carboplatin Accord
- Poland · Carbomedac, Carboplatin Accord
- Portugal · Carboplatina Accord, Carboplatina Generis
- Romania · Carboplatin Actavis, Carboplatin Kabi
- Sweden · Carbomedac, Carboplatin Accord
- Slovenia · Carboplatin Ebewe, Karboplatin Accord
- Slovakia · Carbomedac, Carboplatin Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5cae0d66-7662-4414-8aa0-d535a92d417c GET /v1/drugs/5cae0d66-7662-4414-8aa0-d535a92d417c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Carboplatin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about carboplatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.